Editorial Material
Hematology
Heinz Zoller, Sonja Wagner, Benedikt Schaefer
Summary: This study found that hypophosphataemia is a common side-effect in patients with iron deficiency anaemia treated with ferric carboxymaltose, and it may even require intravenous supplementation of phosphate with unknown long-term consequences.
BRITISH JOURNAL OF HAEMATOLOGY
(2023)
Article
Multidisciplinary Sciences
Saki Tahara, Yoshiro Naito, Keisuke Okuno, Seiki Yasumura, Tetsuo Horimatsu, Junichi Ohno, Isamu Sunayama, Yuki Matsumoto, Eri Manabe, Kumiko Masai, Kohei Azuma, Koichi Nishimura, Kyung-Duk Min, Akiko Goda, Masanori Asakura, Masaharu Ishihara
Summary: Anemia and iron deficiency are common in patients with heart failure, and IV administration of iron improves outcomes in patients with decompensated heart failure and iron deficiency. The current diagnostic methods for iron deficiency have limitations, and alternative methods should be considered. Reticulocyte hemoglobin equivalent (Ret-He) is a potential indicator for iron content, but its clinical utility in patients with heart failure remains uncertain. Further investigation is needed to determine the clinical usefulness of Ret-He in identifying iron deficiency, predicting response to IV iron, and prognosis in patients with heart failure.
SCIENTIFIC REPORTS
(2022)
Article
Medicine, General & Internal
Roberto Minutolo, Patrizia Berto, Maria Elena Liberti, Nicola Peruzzu, Silvio Borrelli, Antonella Netti, Carlo Garofalo, Giuseppe Conte, Luca De Nicola, Lucia Del Vecchio, Francesco Locatelli
Summary: In non-hemodialysis CKD patients, ferric carboxymaltose (FCM) effectively corrects iron-deficient anemia and allows remarkable cost savings from societal, healthcare, and patient perspectives.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Oncology
Burak Yasin Aktas, Emine Busra Ata, Engin Cesmeci, Ibrahim Yahya Cakir, Muharrem Coskunpinar, Yagmur Tahillioglu, Gurkan Guner, Deniz Can Guven, Zafer Arik, Neyran Kertmen, Omer Dizdar, Suayib Yalcin, Sercan Aksoy
Summary: Iron carboxymaltose treatment is an effective and safe alternative for cancer patients with iron-deficiency anemia, showing significant improvement in hemoglobin levels and favorable outcomes across different tumor types.
Article
Public, Environmental & Occupational Health
Carlos Alberto Nogueira-de-Almeida, Daniela Prozorovscaia, Elaine M. Bento Mosquera, Fabio da Veiga Ued, Vanessa Caroline Campos
Summary: This study evaluated the dietary iron intake and dietary practices that interfere with iron absorption among Brazilian children from three regions. It was found that children's diet showed low iron bioavailability and insufficient consumption of iron absorption stimulants, while the frequent presence of iron chelators and inhibitors might explain the high prevalence of iron deficiency.
FRONTIERS IN PUBLIC HEALTH
(2023)
Review
Cardiac & Cardiovascular Systems
Caterina Rizzo, Rosa Carbonara, Roberta Ruggieri, Andrea Passantino, Domenico Scrutinio
Summary: Iron deficiency is a common comorbidity in patients with heart failure and can greatly affect quality of life and prognosis. Treatment guidelines recommend initiating iron replacement therapy based on specific blood markers to improve symptoms and exercise capacity.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)
Article
Clinical Neurology
Hyoeun Bae, Yong Won Cho, Keun Tae Kim, Richard P. Allen, Christopher J. Earley
Summary: This study demonstrates the significant efficacy and safety of FCM 1500mg treatment in both short-term (6 weeks) and long-term (52 weeks) outcomes for RLS patients with IDA. It also shows a significant improvement in sleep quality and a high proportion (61%) of subjects no longer needing RLS medications at the end of the Phase II.
Review
Medicine, General & Internal
Hye Won Shin, Doo Yeon Go, Suk Woo Lee, Yoon Ji Choi, Eun Ji Ko, Hae Sun You, Yoo Kyung Jang
Summary: This systematic review compared the efficacy and safety of ferric carboxymaltose (FCM) and iron sucrose (IS) in treating iron deficiency anemia (IDA) in obstetric and gynecologic patients. The results showed that FCM was more effective in increasing Hb and ferritin levels compared to IS, with a more favorable safety profile.
Letter
Medicine, General & Internal
Natalia Scaramellini, Marco Capecchi, Andrea Artoni, Silvia La Marca, Maria Domenica Cappellini, Irene Motta
Summary: Inherited platelet function defects lead to sub-acute and chronic bleedings, oral iron supplementation for iron deficiency anemia may be insufficient, and intravenous iron is used for severe anemia or GI intolerance. Currently available iron compounds allow high-dose administration with low immunogenicity, though there is limited research on their effectiveness in patients with inherited platelet disorders.
INTERNAL AND EMERGENCY MEDICINE
(2021)
Article
Multidisciplinary Sciences
Tomoya Ueda, Rika Kawakami, Kazutaka Nogi, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Tomoya Nakano, Yukihiro Hashimoto, Hitoshi Nakagawa, Taku Nishida, Kenji Onoue, Tsunenari Soeda, Satoshi Okayama, Makoto Watanabe, Yoshihiko Saito
Summary: In patients with acute decompensated HF, low serum iron level at discharge was identified as an independent predictor of poor prognosis, regardless of hemoglobin or ferritin levels. This suggests a new concept that iron may play a role in the pathophysiology of ADHF through non-hematopoietic mechanisms.
SCIENTIFIC REPORTS
(2021)
Article
Emergency Medicine
Kavya Magham, Josiah Han, Wesley Eilbert, E. Bradshaw Bunney
Summary: This article reports a rare case of severe anemia in a patient with copper deficiency caused by the use of zinc supplement.
AMERICAN JOURNAL OF EMERGENCY MEDICINE
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Mohamad F. Barakat, George Amin-Youseff, Darlington O. Okonko
Summary: This study focuses on the improvement of exercise capacity and quality of life in heart failure patients through oral sucrosomial iron, as a nonrandomized, open-label, proof-of-concept study.
EUROPEAN JOURNAL OF HEART FAILURE
(2021)
Editorial Material
Medicine, General & Internal
Steven Fishbane, Tomas Ganz, Raymond D. Pratt
Summary: Anemia is a common complication in patients with hemodialysis-dependent chronic kidney disease (HDD-CKD), primarily caused by erythropoietin deficiency, inflammation, and iron deficiency. Ferric pyrophosphate citrate (FPC) is a safe and effective choice for iron replacement and maintenance of hemoglobin in the long-term management of HDD-CKD patients.
CURRENT MEDICAL RESEARCH AND OPINION
(2022)
Article
Pediatrics
Patricia Garcia-Ortega, Ines Jimenez-Lozano, Alejandro Cruz, Aurora Fernandez Polo, Mercedes Lopez, Gema Ariceta
Summary: This study retrospectively evaluated the safety and effectiveness of FCM treatment in pediatric patients with CKD non-dependent of hemodialysis. The results showed that FCM can improve anemia and is well-tolerated in pediatric patients with CKD, with a low incidence of adverse effects.
FRONTIERS IN PEDIATRICS
(2022)
Review
Nutrition & Dietetics
Rohil S. Bhatnagar, Olga Padilla-Zakour
Summary: Although malnutrition rates have decreased in India over the past decade due to government interventions, anemia prevalence remains high. The high prevalence is not solely attributed to iron deficiency, as staple foods rich in iron are poorly absorbed due to phytates. Iron supplementation is the common intervention, but its effectiveness is limited by low compliance and irregular supplies.
Letter
Hematology
Arun S. Shet, Laurel Mendelsohn, Julia Harper, David Ostrowski, Eric R. Henry, Eveline Gwaabe, Jim Nichols, Abdu I. Alayash, William A. Eaton, Swee Lay Thein
AMERICAN JOURNAL OF HEMATOLOGY
(2019)
Article
Biochemical Research Methods
Deepsikha Srivastava, Gosala Raja Kukkuta Sarma, Delon Snehal Dsouza, Monita Muralidharan, Krishnamachari Srinivasan, Amit Kumar Mandal
ANALYTICAL BIOCHEMISTRY
(2019)
Article
Biochemical Research Methods
Monita Muralidharan, Vijay Bhat, Y. S. Bindu, Amit Kumar Mandal
ANALYTICAL BIOCHEMISTRY
(2019)
Article
Biochemistry & Molecular Biology
Benita Jebarupa, Boby Mathew, Bindu Y. Srinivasu, Aiswarya Sasikumaran, Smitha Joseph, Amit K. Mandal, Tinku Thomas, Gopa Mitra
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
(2019)
Article
Biochemistry & Molecular Biology
Monita Muralidharan, Amrita Mitra, Dibyajyoti Maity, Debnath Pal, Amit Kumar Mandal
JOURNAL OF STRUCTURAL BIOLOGY
(2019)
Article
Biochemistry & Molecular Biology
Monita Muralidharan, Vijay Bhat, Amit Kumar Mandal
Article
Biochemistry & Molecular Biology
Sreekala Narayanan, Boby Mathew, Bindu Y. Srinivasu, Vijay Bhat, Cecil Ross, Amit Kumar Mandal
Article
Biochemistry & Molecular Biology
Jozefien De Geyter, Athina G. Portaliou, Bindu Srinivasu, Srinath Krishnamurthy, Anastassios Economou, Spyridoula Karamanou
Article
Biochemistry & Molecular Biology
Mehdi Bouhaddou, Danish Memon, Bjoern Meyer, Kris M. White, Veronica V. Rezelj, Miguel Correa Marrero, Benjamin J. Polacco, James E. Melnyk, Svenja Ulferts, Robyn M. Kaake, Jyoti Batra, Alicia L. Richards, Erica Stevenson, David E. Gordon, Ajda Rojc, Kirsten Obernier, Jacqueline M. Fabius, Margaret Soucheray, Lisa Miorin, Elena Moreno, Cassandra Koh, Quang Dinh Tran, Alexandra Hardy, Remy Robinot, Thomas Vallet, Benjamin E. Nilsson-Payant, Claudia Hernandez-Armenta, Alistair Dunham, Sebastian Weigang, Julian Knerr, Maya Modak, Diego Quintero, Yuan Zhou, Aurelien Dugourd, Alberto Valdeolivas, Trupti Patil, Qiongyu Li, Ruth Huttenhain, Merve Cakir, Monita Muralidharan, Minkyu Kim, Gwendolyn Jang, Beril Tutuncuoglu, Joseph Hiatt, Jeffrey Z. Guo, Jiewei Xu, Sophia Bouhaddou, Christopher J. P. Mathy, Anna Gaulton, Emma J. Manners, Eloy Felix, Ying Shi, Marisa Goff, Jean K. Lim, Timothy McBride, Michael C. O'Neal, Yiming Cai, Jason C. J. Chang, David J. Broadhurst, Saker Klippsten, Emmie De Wit, Andrew R. Leach, Tanja Kortemme, Brian Shoichet, Melanie Ott, Julio Saez-Rodriguez, Benjamin R. TenOever, R. Dyche Mullins, Elizabeth R. Fischer, Georg Kochs, Robert Grosse, Adolfo Garcia-Sastre, Marco Vignuzzi, Jeffery R. Johnson, Kevan M. Shokat, Danielle L. Swaney, Pedro Beltrao, Nevan J. Krogan
Review
Hematology
Arun S. Shet, Maria A. Lizarralde-Iragorri, Rakhi P. Naik
Article
Biochemical Research Methods
Paige Haas, Monita Muralidharan, Nevan J. Krogan, Robyn M. Kaake, Ruth Huttenhain
Summary: The article discusses how proteomic research can investigate four key areas of SARS-CoV-2 biology through technologies, including solving structural issues through mass spectrometry, identifying virus-host protein-protein interactions, analyzing changes in signaling pathways during infection, and using proteomic technologies for biomarker identification and drug development.
JOURNAL OF PROTEOME RESEARCH
(2021)
Article
Hematology
Ashima Singh, Amanda M. Brandow, Ted Wun, Arun S. Shet
Summary: This study found that hospitalization with COVID-19 does not increase the risk of venous thromboembolism (VTE) in patients with sickle cell disease (SCD) compared to those hospitalized for other reasons.
Editorial Material
Hematology
Arun S. Shet
Summary: Finally, it is important to consider the implications of this study for human myeloid disease. A certain genetic variant near MYB has been associated with an increased risk of developing myeloproliferative neoplasias (MPNs). Additionally, this variant appears to significantly reduce MYB expression in myeloid and erythroid progenitors. These findings support the idea that even a moderate reduction in MYB expression can predispose individuals to the development of MNs, highlighting the importance of precise regulation of MYB expression.
Article
Multidisciplinary Sciences
Sreekala Narayanan, Boby Mathew, Bindu Y. Srinivasu, Monita Muralidharan, Vijay Bhat, Amit Kumar Mandal